News MimiVax and Roswell Park Announce Results from Phase 2b SURVIVE Trial of SurVaxM in Newly Diagnosed Glioblastoma
News Roswell Park to Spotlight Advances in AI, Immunotherapy and Surgery at International Head/Neck Cancer Meeting